The report is available in English with a French summary - KCE

More documents

Recommendations

Info

14 Plasma KCE Reports 120 2.1.2.2 Collected Quantities Ninety six percent of the blood and plasma donations in Belgium are collected by the Red Cross, which has been placed under the responsibility of the Belgian Red Cross since its inception in 1935. Four non Red Cross blood centres, at Charleroi Hospital and UCL Hospital Mont-Godinne, AZ Sint-Jan Brugge and the Service militaire du sang account for the remaining blood collections. All donations are made by voluntary noncompensated donors, although some donors (from public sector) may receive time off work in addition to the time for donation. Although the Red Cross collects donations by plasmapheresis (source plasma), the bigger part of plasma intended for fractionation is recovered plasma (from whole blood donations). This report focuses solely on the two organizations which form the “transfusion service”: The SFS = le Service Francophone du Sang and the VDB = De Vlaamse Dienst voor het Bloed. Table 1 and figure 1 show the trend in donations of whole blood and plasmapheresis from 2000 to 2008. We note that the overall number of donations of whole blood is very stable between the start and end of the period under review. However, this stability between these two dates (2000 and 2008) obscures the fall at the start of the period (from 513 762 donations in 2000 to 503 247 in 2003 and the strong growth (+ 4.7%) in 2004. Since then, the number of donations fell again before recovering in 2008. Comparing the trend in the French-speaking section of the Red Cross (SFS) with that of the Dutch-speaking section (VDB), we find a contrasting situation resulting in stability from a reduction of more than 11 000 units for the VDB offset by a rise of almost 11 000 units for the SFS, which is partially artificial as it follows the integration of two independent centres by the SFS (the transfusion centre in Brussels in 2003 and the Hustin centre in 2004) in the SFS activities. As for the number of plasmapheresis donations, the trend is clearly downwards, -56% for the VDB and -63% for the SFS over the period in question as a whole. It seems that the drop in the number of donations of source plasma is linked to the closure of plasmapheresis centres. Globally, the number of donors is quite stable during the last three years (+ 2%), resulting from a combination of a decreasing for the VDB (-1.5%) and a substantial increasing for the SFS (+9%). Table 1: Number of donations collected by SFS and VDB and number of donors 2000 2001 2002 2003 2004 2005 2006 2007 2008 Number of donations whole blood SFS 162.101 155.083 151.835 159.083 173.602 167.902 161.499 162.474 173.083 Number of donations whole blood VDB 351.661 346.036 344.370 344.145 353.337 353.017 349.483 337.246 340.237 Total number of donations whole blood 513.762 501.119 496.205 503.228 526.939 520.919 510.982 499.720 513.320 Number of donations plasmapheresis SFS 44.569 44.515 37.791 36.106 34.691 20.538 17.013 17.021 16.315 Number of donations plasmapheresis VDB 122.518 120.653 128.727 118.700 115.898 100.654 72.167 60.962 53.568 Total number of donations plasmapheresis 167.087 165.168 166.518 154.806 150.589 121.192 89.180 77.983 69.883 Number of donations cytapheresis SFS 10.776 10.155 9.994 9.995 12.066 11.921 10.293 8.861 8.582 Number of donations cytapheresis VDB 7.768 8.623 8.884 7.403 13.662 13.489 12.512 13.107 13.164 Total number of donations cytapheresis 18.544 18.778 18.878 17.398 25.728 25.410 22.805 21.968 21.746 Number of donors whole blood SFS 91.422 91.009 98.953 89.767 85.654 82.972 80.628 82.353 87.875 Number of donors whole blood VDB 160.048 158.901 156.684 155.992 155.881 153.508 156.810 150.187 154.426 Total number of donors whole blood 251.470 249.910 255.637 245.759 241.535 236.480 237.438 232.540 242.301 Source : SFS & VDB
KCE Reports 120 Plasma 15 Number of donations Figure 1: Number of donations collected by SFS and VDB 600.000 500.000 400.000 300.000 200.000 100.000 0 Source : SFS & VDB 513.762 513.317 167.087 69.883 Whole blood VDB Plasmapheresis VDB Whole blood SFS Plasmapheresis SFS Total Blood Total plasmapheresis In the following table we present the evolution of the volume of plasma collected by the SFS and the VDB during the period 2000-2008. The plasma from whole blood is decreasing in volume with 14.5% and the plasma from plasmapheresis is decreasing in volume with 41.4%. Globally, the total volume of plasma decreases with 24.6% Table 2: Volume of plasma in litres collected by SFS and VDB 2000 2001 2002 2003 2004 2005 2006 2007 2008 Volume of plasma from whole blood SFS 36.148 38.643 35.304 39.529 36.762 35.350 34.565 35.461 37.164 Volume of plasma from whole blood VDB 89.326 86.014 88.061 84.639 79.393 73.340 70.526 70.533 70.139 Volume of plasma from whole blood SFS + VDB 125.474 124.657 123.365 124.168 116.155 108.690 105.091 105.994 107.303 Volume of plasma from plasmapheresis & cytapheresis SFS 16.662 18.428 17.339 14.932 23.814 17.825 13.642 13.499 13.255 Volume of plasma from plasmapheresis & cytapheresis VDB 60.390 59.380 57.526 52.983 70.362 60.243 43.583 36.626 32.069 Volume of plasma from plasmapheres. & cytapheres. SFS + VDB 77.052 77.808 74.865 67.915 94.176 78.068 57.225 50.125 45.324 Total volume of plasma collected by SFS + VDB 202.526 202.465 198.230 192.083 210.331 186.758 162.316 156.119 152.627 Source : SFS & VDB It seems that the collection of plasma is a quite flexible activity. Indeed in 2004-2005, the demand has increased and SFS and VDB have collected more plasma from plasmapheresis to meet the increased demand.
Page 1 and 2: Comment assurer l’autosuffisance
Page 3 and 4: Comment assurer l’autosuffisance
Page 5 and 6: KCE Reports 120B Plasma i PRÉFACE
Page 7 and 8: KCE Reports 120B Plasma iii MÉTHOD
Page 9 and 10: KCE Reports 120B Plasma v En ce qui
Page 11 and 12: KCE Reports 120B Plasma vii RECOMMA
Page 13 and 14: KCE Reports 120 Plasma 1 Scientific
Page 15 and 16: KCE Reports 120 Plasma 3 GLOSSARY A
Page 17 and 18: KCE Reports 120 Plasma 5 1 INTRODUC
Page 19 and 20: KCE Reports 120 Plasma 7 Focus: sta
Page 21 and 22: KCE Reports 120 Plasma 9 Two techni
Page 23 and 24: KCE Reports 120 Plasma 11 Therefore
Page 25: KCE Reports 120 Plasma 13 FRENCH-SP
Page 29 and 30: KCE Reports 120 Plasma 17 Table 4:
Page 35 and 36: KCE Reports 120 Plasma 23 Role of t
Page 37 and 38: KCE Reports 120 Plasma 25 2.1.3.2 P
Page 39 and 40: KCE Reports 120 Plasma 27 • 73% o
Page 41 and 42: KCE Reports 120 Plasma 29 2.2 TRANS
Page 43 and 44: KCE Reports 120 Plasma 31 Figure 6:
Page 45 and 46: KCE Reports 120 Plasma 33 GEOGRAPHI
Page 47 and 48: KCE Reports 120 Plasma 35 It is sur
Page 49 and 50: KCE Reports 120 Plasma 37 Plasma fr
Page 51 and 52: KCE Reports 120 Plasma 39 2.3 LIMIT
Page 55 and 56: KCE Reports 120 Plasma 43 3.2 INDIC
Page 57 and 58: KCE Reports 120 Plasma 45 Subcutane
Page 61 and 62: KCE Reports 120 Plasma 49 3.2.2 Evi
Page 63 and 64: KCE Reports 120 Plasma 51 Search re
Page 65 and 66: KCE Reports 120 Plasma 53 CIDP IG i
Page 67 and 68: KCE Reports 120 Plasma 55 • IG re
Page 69 and 70: KCE Reports 120 Plasma 57 Solid org
Page 71 and 72: KCE Reports 120 Plasma 59 A Cochran
Page 73 and 74: KCE Reports 120 Plasma 61 • In ch
Page 75 and 76: KCE Reports 120 Plasma 63 Two small
Page 77 and 78:
KCE Reports 120 Plasma 65 was lower
Page 79 and 80:
KCE Reports 120 Plasma 67 Three RCT
Page 81 and 82:
KCE Reports 120 Plasma 69 Severe se
Page 83 and 84:
KCE Reports 120 Plasma 71 The analy
Page 85 and 86:
KCE Reports 120 Plasma 73 3.3.1.2 T
Page 87 and 88:
KCE Reports 120 Plasma 75 Figure 7:
Page 89 and 90:
KCE Reports 120 Plasma 77 Figure 10
Page 91 and 92:
KCE Reports 120 Plasma 79 Table 30:
Page 93 and 94:
KCE Reports 120 Plasma 81 Table 36:
Page 95 and 96:
KCE Reports 120 Plasma 83 • For b
Page 97 and 98:
KCE Reports 120 Plasma 85 3.3.2.6 L
Page 99 and 100:
KCE Reports 120 Plasma 87 • The p
Page 101 and 102:
KCE Reports 120 Plasma 89 In Belgiu
Page 103 and 104:
KCE Reports 120 Plasma 91 Multifoca
Page 105 and 106:
KCE Reports 120 Plasma 93 Based on
Page 107 and 108:
KCE Reports 120 Plasma 95 Disease /
Page 109 and 110:
KCE Reports 120 Plasma 97 3.3.4 Exp
Page 111 and 112:
KCE Reports 120 Plasma 99 Figure 12
Page 113 and 114:
KCE Reports 120 Plasma 101 Key poin
Page 115 and 116:
KCE Reports 120 Plasma 103 Key poin
Page 117 and 118:
KCE Reports 120 Plasma 105 • Conf
Page 119 and 120:
KCE Reports 120 Plasma 107 As far a
Page 121 and 122:
KCE Reports 120 Plasma 109 Followin
Page 123 and 124:
KCE Reports 120 Plasma 111 4.3 HOW
Page 125 and 126:
KCE Reports 120 Plasma 113 Improvin
Page 127 and 128:
KCE Reports 120 Plasma 115 4.3.2 St
Page 129 and 130:
KCE Reports 120 Plasma 117 4.4 CONC
Page 131 and 132:
KCE Reports 120 Plasma 119 FAVOURIN
Page 133 and 134:
KCE Reports 120 Plasma 121 APPENDIX
Page 135 and 136:
KCE Reports 120 Plasma 123 For othe
Page 137 and 138:
KCE Reports 120 Plasma 125 Table 48
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
KCE Reports 120 Plasma 131 Distribu
Page 145 and 146:
KCE Reports 120 Plasma 133 • Conv
Page 147 and 148:
Page 149 and 150:
KCE Reports 120 Plasma 137 6 REFERE
Page 151 and 152:
KCE Reports 120 Plasma 139 41. Pruz
Page 153 and 154:
KCE Reports 120 Plasma 141 82. Comi
Page 155 and 156:
KCE Reports 120 Plasma 143 123. Cre
Page 157 and 158:
KCE Reports 120 Plasma 145 165. Cua
Page 159 and 160:
This page is left intentionally bla
Page 161 and 162:
KCE reports 1. Efficacité et renta
Page 163 and 164:
73. Financement du programme de soi
show all

The report is available in English with a French summary - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?